Momentum for railway, defence in India Budget
The provision of Rs 1 lakh crore for R&D is a ground-breaking move
Stay updated with breaking news from Data Patterns. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The provision of Rs 1 lakh crore for R&D is a ground-breaking move
Larsen & Toubro: Recorded a 15 percent year-on-year growth in consolidated net profit at Rs 2,947 crore during Q3. EBITDA margin dropped by 50 basis points to 10.4 percent for the quarter. Dr. Reddy’s: Saw a 10.6 percent year-on-year growth in consolidated net profit at Rs 1,378.9 crore, despite higher tax costs. SRF: Saw a 50.4 percent year-on-year decline in consolidated net
Sun Pharmaceuticals and Maruti Suzuki India are among the companies declaring their Q3FY24 earnings. Maruti Suzuki India is expected to report healthy revenue growth, while Sun Pharmaceuticals may see moderate revenue growth.
As long as the stock is priced above the 200-day SMA on the daily time frame, it is generally considered to be an overall uptrend.
Some of the top themes this interim budget will focus on include rail, infra, defence, manufacturing, clean tech, and affordable housing